Literature DB >> 7410041

The quantitative reduction by heparin of intravenous thrombosis in normal and hypercoagulable animals.

S M Lavelle, M Maclomhair.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7410041     DOI: 10.1007/bf02939152

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


× No keyword cloud information.
  6 in total

1.  STUDIES ON THE PATHOGENESIS OF THROMBOSIS: AN EXPERIMENTAL "HYPERCOAGULABLE" STATE INDUCED BY THE INTRAVENOUS INJECTION OF ELLAGIC ACID.

Authors:  R E BOTTI; O D RATNOFF
Journal:  J Lab Clin Med       Date:  1964-09

2.  The effect of adrenaline infusion on human blood coagulation.

Authors:  G D FORWELL; G I INGRAM
Journal:  J Physiol       Date:  1957-02-15       Impact factor: 5.182

3.  A brain extract as a substitute for platelet suspensions in the thromboplastin generation test.

Authors:  W N BELL; H G ALTON
Journal:  Nature       Date:  1954-11-06       Impact factor: 49.962

Review 4.  Heparin Therapy: regimens and management.

Authors:  D Deykin
Journal:  Drugs       Date:  1977-01       Impact factor: 9.546

5.  Effect of 1-methyl-2-mercapto-5-(3-pyridyl)-imidazole (KC-6141), an anti-aggregating compound, on experimental thrombosis in rats.

Authors:  T Umetsu; K Sanai
Journal:  Thromb Haemost       Date:  1978-02-28       Impact factor: 5.249

6.  Thrombus weight as a measure of hypercoagulability induced by drugs.

Authors:  M MacIomhair; S M Lavelle
Journal:  Thromb Haemost       Date:  1979-10-31       Impact factor: 5.249

  6 in total
  2 in total

1.  Bleeding times and the antithrombotic effects of high-dose aspirin, hirudin and heparins in the rat.

Authors:  S M Lavelle; M MacIomhair
Journal:  Ir J Med Sci       Date:  1998 Oct-Dec       Impact factor: 1.568

2.  The anticoagulant, antithrombotic and haemorrhagic effect of long-term warfarin on experimental venous and arterial thrombosis in the rat.

Authors:  M MacIomhair; S M Lavelle
Journal:  Ir J Med Sci       Date:  1996 Jul-Sep       Impact factor: 1.568

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.